Hinge Health, Inc. (NYSE:HNGE) is a digital physical therapy platform that saw its stock price rise from $44 to $55 after reporting a stellar first quarter post-IPO. Jim Cramer recommended buying the stock, praising its innovative approach to therapy via phone instead of in-person visits.

Cramer’s insights on Hinge Health, Inc. (NYSE:HNGE) highlight the company’s focus on musculoskeletal care, injury recovery, pain management, and post-surgical rehab. The stock surged to $52 after analysts gave positive coverage in June, then dipped to the mid-$40s. Cramer sees potential in the stock’s pullback and long-term growth prospects.

Read more at Yahoo Finance: “I Told You it Was Worth Buying”